Home » Topics » BioWorld Science

BioWorld Science
RSS

Rapalimus gel launched in Japan for the treatment of angiofibromas in tuberous sclerosis

June 11, 2018

Amgen presents new apelin receptor agonists

June 11, 2018

Merck & Co. identifies Nav1.7 channel blockers

June 11, 2018

Prolia approved in Europe for patients with glucocorticoid-induced osteoporosis

June 11, 2018

Bristol-Myers Squibb divulges integrin alphaV antagonists

June 11, 2018

Dana-Farber Cancer Institute patents new PROTAC compounds for cancer

June 11, 2018

Modest data for PI3K inhibitor taselisib in breast cancer

June 11, 2018

Bayer closes its acquisition of Monsanto

June 11, 2018

NOSO-502: a new antibacterial drug candidate active against carbapenem-resistant Enterobacteriaceae

June 11, 2018

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...